<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-21309" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Erythrokeratodermia Variabilis</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Chouk</surname>
            <given-names>Chourouk</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Litaiem</surname>
            <given-names>Noureddine</given-names>
          </name>
          <aff>University of Tunis El Manar</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Chourouk Chouk declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Noureddine Litaiem declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>23</day>
          <month>5</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-21309.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Erythrokeratodermia is a group of inherited disorders characterized by well-demarcated erythematous lesions and hyperkeratotic plaques. Erythrokeratodermia variabilis (EKV), formerly known as Mendes da Costa syndrome, usually involves migratory red patches along with fixed localized or generalized keratotic plaques. Later, clinical features of progressive symmetric erythrokeratodermia (PSEK) were observed within a single family that also had EKV features. The former thinking that these diseases were distinct entities changed, and EKV and PSEK subsequently have been considered manifestations of a single inherited clinical entity. With the identification of the same gene mutation in patients with EKV and PSEK, some authors proposed the designation of erythrokeratodermia variabilis progressiva (EKVP) to encompass the diversity of the clinical phenotypes of both EKV and PSEK. This activity explains when erythrokeratodermia variabilis should be considered, how to properly evaluate for this condition, and highlights the role of the interprofessional team in caring for patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the various presenting features of erythrokeratodermia variabilis.</p></list-item><list-item><p>Describe the evaluation of a patient suspected to have erythrokeratodermia variabilis.</p></list-item><list-item><p>Summarize the treatment of erythrokeratodermia variabilis.</p></list-item><list-item><p>Outline the importance of enhancing care coordination among the interprofessional team to ensure proper evaluation and management of erythrokeratodermia variabilis.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=21309&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=21309">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-21309.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Erythrokeratodermia is a group of inherited disorders characterized by well-demarcated erythematous lesions and hyperkeratotic plaques. Connexin mutations have been demonstrated to be responsible for most cases of erythrokeratodermia variabilis (EKV). In this condition, we usually observe migratory red patches along with fixed localized or generalized keratotic plaques. Erythrokeratodermia variabilis was also known as Mendes da Costa syndrome.<xref ref-type="bibr" rid="article-21309.r1">[1]</xref> Later, clinical features of progressive symmetric erythrokeratodermia (PSEK), which is known to induce stationary erythematous progressive plaques, were observed within a single family association with EKV features.<xref ref-type="bibr" rid="article-21309.r2">[2]</xref> Therefore, the thinking became that the two diseases (EKV and PSEK) were different manifestations of a single inherited clinical entity. And with the identification of the same gene mutation in patients with EKV and PSEK, some authors proposed the designation of erythrokeratodermia variabilis progressiva (EKVP) to encompass the diversity of the clinical phenotypes of both EKV and PSEK.<xref ref-type="bibr" rid="article-21309.r3">[3]</xref></p>
      </sec>
      <sec id="article-21309.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Erythrokeratodermia variabilis demonstrates heterozygous dominant inheritance. EKV-associated mutations are usually located in genes encoding either Cx31 (GJB3) or Cx30.3 (GJB4) and occasionally Cx43 (GJA1).<xref ref-type="bibr" rid="article-21309.r4">[4]</xref> These proteins (connexin 31, connexin 30.3, and connexin 43) are gap junc&#x000ad;tion proteins that belong to a large family of transmembrane proteins forming intercellular channels. Gap junctions are responsible for the exchange of metabolites, ions, and secondary messengers between cells. The connexin family in humans consists of at least 20 distinct proteins, and most cell types and tissues express more than one connexin gene.<xref ref-type="bibr" rid="article-21309.r5">[5]</xref> Connexin 31 expresses in the skin, peripheral nerves, and the cochlea.<xref ref-type="bibr" rid="article-21309.r6">[6]</xref> Cx30.3 expresses in the skin, kidney, and preimplantation blastocyst.<xref ref-type="bibr" rid="article-21309.r7">[7]</xref> Cx43 is ubiquitously expressed.<xref ref-type="bibr" rid="article-21309.r8">[8]</xref> All reported mutations in EKV are non-conservative amino acid substitution mutations, resulting in impaired epidermal differentiation.</p>
        <p>There are reports of rare forms inherited with autosomal recessive modality caused by homozygous mutations in GJB3 that were also described in patients with EKV, although EKV is admittedly a consequence of connexin mutations.<xref ref-type="bibr" rid="article-21309.r9">[9]</xref><xref ref-type="bibr" rid="article-21309.r10">[10]</xref> Cases with typical features of EKV were not associated with this group of mutations.<xref ref-type="bibr" rid="article-21309.r11">[11]</xref></p>
        <p>In a study by Common et al., molecular investigations of GJB3 and GJB4 were performed in five pedigrees and three sporadic cases of EKV. The detection of connexin 31(Cx31) or connexin 30.3 (Cx30.3) mutations was in only three probands, of which two were novel mutations, and one was a recurrent mutation. Also, no mutations in these patients were detected in other epidermal disease-associated Cx genes. The authors conclude that EKV is a heterogeneous condition, and individuals clinically diagnosed with this disease harbor different Cx31 or Cx30.3 mutations.<xref ref-type="bibr" rid="article-21309.r12">[12]</xref></p>
      </sec>
      <sec id="article-21309.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Erythrokeratodermia variabilis lesions are usually present in the first year of life and less frequently since birth.<xref ref-type="bibr" rid="article-21309.r13">[13]</xref> More rarely, EKV occurs later in childhood and even in early adult life.<xref ref-type="bibr" rid="article-21309.r14">[14]</xref> It is a rare disorder, predominantly transmitted in an autosomal dominant manner.<xref ref-type="bibr" rid="article-21309.r4">[4]</xref> The disease shows nearly complete penetrance but with considerable variability. There is documentation of a few cases of autosomal recessive inheritance.</p>
      </sec>
      <sec id="article-21309.s5" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Histopathological examination shows only non-specific findings, including papillomatosis, moderate to severe acanthosis, hypergranulosis composed of two to four layer cells, compact hyperkeratosis or parakeratosis, and follicular plugging. In the papillary dermis, there are dilated, elongated capillaries with a variable perivascular inflammatory infiltrate.<xref ref-type="bibr" rid="article-21309.r2">[2]</xref> An aspect of suprapapillary thinning is a possible presenting sign, and when it is associated with severe papilloma&#x000ad;tosis, this may result in a &#x0201c;church spire&#x0201d; con&#x000ad;figuration of the epidermis. Ultrastructural studies show a decreased number of lamellar bodies in the granular layer.<xref ref-type="bibr" rid="article-21309.r15">[15]</xref></p>
      </sec>
      <sec id="article-21309.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>There are two characteristic types of lesions:</p>
        <list list-type="bullet">
          <list-item>
            <p>Transient erythematous patches</p>
          </list-item>
          <list-item>
            <p>Stable hyperkeratotic plaques</p>
          </list-item>
        </list>
        <p>Usually, one of these two features predominates, and occasionally one is missing. Migratory-shaped red areas are the initial presenting sign. These lesions are usually well-demarcated with a map-like or annular appearance. They can coalesce into large figurate patches, which vary in shape, size, number, and position over minutes, hours, or, more often, days.<xref ref-type="bibr" rid="article-21309.r1">[1]</xref> A blanched halo may also surround the plaques. Emotional stress, environmental heat or cold, mechan&#x000ad;ical friction, and sun exposure may cause more prominent erythematous lesions.<xref ref-type="bibr" rid="article-21309.r16">[16]</xref> Stable hyperkeratotic plaques with scaling of the skin evolve simultaneously with or following the development of migratory red patches. These former lesions are usually well-demarcated, yellow to brown, and often on a red basis. They are thickened plaques exhibiting a geographic morphology. Sometimes it is so thick and dark that it manifests as a hystrix-like appearance. Moreover, hypertrichosis may present as well as a collarette-like peeling or psoriasiform scales.</p>
        <p>Some atypical features of the disease are thought to be a probable clinical variant of EKV. That includes lesions resembling erythema gyratum repens,<xref ref-type="bibr" rid="article-21309.r17">[17]</xref> with a mutation in the Cx30.3 gene identified in these families. Erythrokeratodermia en cocarde is made of circinate or gyrate erythematous patches and has correlations with mutations in <italic toggle="yes">GJB4</italic>.<xref ref-type="bibr" rid="article-21309.r18">[18]</xref> Some other cases present with erythema annulare centrifugum-like lesions.<xref ref-type="bibr" rid="article-21309.r1">[1]</xref></p>
        <p>The lesions of EKV have a predilection for the extensor aspects of the limbs, buttocks, and lateral trunk in an almost symmetric distribution.<xref ref-type="bibr" rid="article-21309.r5">[5]</xref> In half of all patients, the thickening of the skin extends onto the palms and soles, resulting in palmoplantar keratoderma. Face, scalp, and flexures tend to be spared, but any part of the skin surface may be involved.<xref ref-type="bibr" rid="article-21309.r1">[1]</xref> Skin appendages, like hair, teeth, and nails, are unaffected by this disease, and their growth and development progress normally.</p>
        <p>Symptoms like a burning sensation in erythematous lesions may cause discomfort in some patients.<xref ref-type="bibr" rid="article-21309.r16">[16]</xref> EKV tends to stabilize after puberty. However, the duration of the overall condition is lifelong, but an improvement over time and periodic clearing of the skin is also possible.</p>
      </sec>
      <sec id="article-21309.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Erythrokeratodermia variabilis is mostly a skin-limited condition. Nevertheless, the evaluation of systemic manifestations is necessary to eliminate other variants of erythrokeratodermia that can mimic EKV clinically. These include KID syndrome with erythrokeratodermia-like lesions. In this condition, keratitis, hearing loss, alopecia, and increased susceptibility to infection are present. Moreover, reports exist of neurological symptoms in association with EKV-like lesions including ataxia, and peripheral neuropathy.<xref ref-type="bibr" rid="article-21309.r1">[1]</xref></p>
      </sec>
      <sec id="article-21309.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Therapy is almost symptomatic and depends on the severity and extent of the hyperkeratosis. Topical management is indicated in mild forms include emollients, topical retinoids, and keratolytic. Systemic retinoids with doses considerably lower compared with those required for other disorders of cornification may be beneficial in some extensive and severe forms.<xref ref-type="bibr" rid="article-21309.r19">[19]</xref> These agents often cause a remarkable improvement and, in some cases, a complete clearing of the hyperkeratosis. Retinoids show a lower response in relieving erythematous lesions. This latter often results in cosmetic concerns, which may require by using camouflage makeup. Patients should ideally avoid sudden temperature changes, friction, and irritation.</p>
        <p>Recently, novel therapies targeting connexin hemichannels and gap junctions with a direct inhibitory action are being studied and may become available in the future.<xref ref-type="bibr" rid="article-21309.r4">[4]</xref></p>
      </sec>
      <sec id="article-21309.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Although lesions in erythrokeratodermia variabilis may closely resemble in early stages those of urticaria, differentiating factors include the longer duration of the disease and the occasional presence of scales.<xref ref-type="bibr" rid="article-21309.r1">[1]</xref> When fixed plaques, psoriasis is distinguished by histopathological examination.</p>
        <p>In Netherton syndrome, ichthyosis demonstrates migratory and serpiginous red plaques that are typical with double-edged scaly borders, and patients usually have other manifestations, including hair shaft abnormalities, eczematous lesions, and pruritus. Differential diagnosis also includes different rare types of ichthyosis such as erythrokeratolysis hiemalis, epidermolytic ichthyosis due to <italic toggle="yes">KRT1 </italic>and <italic toggle="yes">KRT10 </italic>mutations, and Greither syndrome.</p>
      </sec>
      <sec id="article-21309.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Except for the aesthetic prognosis, erythrokeratodermia variabilis is a benign affection with no extracutaneous manifestations.</p>
      </sec>
      <sec id="article-21309.s11" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Erythrokeratodermia variabilis is a genetically determined condition that can easily be confused with more common dermatoses like psoriasis or urticaria. Pediatricians, as well as dermatologists, primary care physicians, and nurse practitioners, and nurses with specialty training in dermatology should be aware of this condition to provide genetic counseling in families with identified mutations and work in an interprofessional team approach to this rare condition for optimal patient care and clinical results. [Level 5]</p>
      </sec>
      <sec id="article-21309.s12">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=21309&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=21309">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/genetic-disorders/erythrokeratodermia-variabilis/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=21309">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/21309/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=21309">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-21309.s13">
        <title>References</title>
        <ref id="article-21309.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rogers</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Erythrokeratodermas: a classification in a state of flux?</article-title>
            <source>Australas J Dermatol</source>
            <year>2005</year>
            <month>Aug</month>
            <volume>46</volume>
            <issue>3</issue>
            <fpage>127</fpage>
            <page-range>127-41; quiz 142</page-range>
            <pub-id pub-id-type="pmid">16008642</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21309.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Macfarlane</surname>
                <given-names>AW</given-names>
              </name>
              <name>
                <surname>Chapman</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Verbov</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>Is erythrokeratoderma one disorder? A clinical and ultrastructural study of two siblings.</article-title>
            <source>Br J Dermatol</source>
            <year>1991</year>
            <month>May</month>
            <volume>124</volume>
            <issue>5</issue>
            <fpage>487</fpage>
            <page-range>487-91</page-range>
            <pub-id pub-id-type="pmid">1828175</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21309.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>van Steensel</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Oranje</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>van der Schroeff</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Wagner</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>van Geel</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>The missense mutation G12D in connexin30.3 can cause both erythrokeratodermia variabilis of Mendes da Costa and progressive symmetric erythrokeratodermia of Gottron.</article-title>
            <source>Am J Med Genet A</source>
            <year>2009</year>
            <month>Feb</month>
            <day>15</day>
            <volume>149A</volume>
            <issue>4</issue>
            <fpage>657</fpage>
            <page-range>657-61</page-range>
            <pub-id pub-id-type="pmid">19291775</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21309.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ishida-Yamamoto</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Erythrokeratodermia variabilis et progressiva.</article-title>
            <source>J Dermatol</source>
            <year>2016</year>
            <month>Mar</month>
            <volume>43</volume>
            <issue>3</issue>
            <fpage>280</fpage>
            <page-range>280-5</page-range>
            <pub-id pub-id-type="pmid">26945536</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21309.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Richard</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Connexins: a connection with the skin.</article-title>
            <source>Exp Dermatol</source>
            <year>2000</year>
            <month>Apr</month>
            <volume>9</volume>
            <issue>2</issue>
            <fpage>77</fpage>
            <page-range>77-96</page-range>
            <pub-id pub-id-type="pmid">10772382</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21309.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>L&#x000f3;pez-Bigas</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Oliv&#x000e9;</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rabionet</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ben-David</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Mart&#x000ed;nez-Matos</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Bravo</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Banchs</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Volpini</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Gasparini</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Avraham</surname>
                <given-names>KB</given-names>
              </name>
              <name>
                <surname>Ferrer</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Arbon&#x000e9;s</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Estivill</surname>
                <given-names>X</given-names>
              </name>
            </person-group>
            <article-title>Connexin 31 (GJB3) is expressed in the peripheral and auditory nerves and causes neuropathy and hearing impairment.</article-title>
            <source>Hum Mol Genet</source>
            <year>2001</year>
            <month>Apr</month>
            <day>15</day>
            <volume>10</volume>
            <issue>9</issue>
            <fpage>947</fpage>
            <page-range>947-52</page-range>
            <pub-id pub-id-type="pmid">11309368</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21309.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>White</surname>
                <given-names>TW</given-names>
              </name>
              <name>
                <surname>Bruzzone</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Multiple connexin proteins in single intercellular channels: connexin compatibility and functional consequences.</article-title>
            <source>J Bioenerg Biomembr</source>
            <year>1996</year>
            <month>Aug</month>
            <volume>28</volume>
            <issue>4</issue>
            <fpage>339</fpage>
            <page-range>339-50</page-range>
            <pub-id pub-id-type="pmid">8844331</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21309.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Laird</surname>
                <given-names>DW</given-names>
              </name>
            </person-group>
            <article-title>Syndromic and non-syndromic disease-linked Cx43 mutations.</article-title>
            <source>FEBS Lett</source>
            <year>2014</year>
            <month>Apr</month>
            <day>17</day>
            <volume>588</volume>
            <issue>8</issue>
            <fpage>1339</fpage>
            <page-range>1339-48</page-range>
            <pub-id pub-id-type="pmid">24434540</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21309.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gottfried</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Landau</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Glaser</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Di</surname>
                <given-names>WL</given-names>
              </name>
              <name>
                <surname>Ophir</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mevorah</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Ben-Tal</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Kelsell</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>Avraham</surname>
                <given-names>KB</given-names>
              </name>
            </person-group>
            <article-title>A mutation in GJB3 is associated with recessive erythrokeratodermia variabilis (EKV) and leads to defective trafficking of the connexin 31 protein.</article-title>
            <source>Hum Mol Genet</source>
            <year>2002</year>
            <month>May</month>
            <day>15</day>
            <volume>11</volume>
            <issue>11</issue>
            <fpage>1311</fpage>
            <page-range>1311-6</page-range>
            <pub-id pub-id-type="pmid">12019212</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21309.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Armstrong</surname>
                <given-names>DK</given-names>
              </name>
              <name>
                <surname>Hutchinson</surname>
                <given-names>TH</given-names>
              </name>
              <name>
                <surname>Walsh</surname>
                <given-names>MY</given-names>
              </name>
              <name>
                <surname>McMillan</surname>
                <given-names>JC</given-names>
              </name>
            </person-group>
            <article-title>Autosomal recessive inheritance of erythrokeratoderma variabilis.</article-title>
            <source>Pediatr Dermatol</source>
            <year>1997</year>
            <season>Sep-Oct</season>
            <volume>14</volume>
            <issue>5</issue>
            <fpage>355</fpage>
            <page-range>355-8</page-range>
            <pub-id pub-id-type="pmid">9336804</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21309.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Arita</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Akiyama</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tsuji</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Onozuka</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Shimizu</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Erythrokeratoderma variabilis without connexin 31 or connexin 30.3 gene mutation: immunohistological, ultrastructural and genetic studies.</article-title>
            <source>Acta Derm Venereol</source>
            <year>2003</year>
            <volume>83</volume>
            <issue>4</issue>
            <fpage>266</fpage>
            <page-range>266-70</page-range>
            <pub-id pub-id-type="pmid">12926797</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21309.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Common</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>O'Toole</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Leigh</surname>
                <given-names>IM</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Griffiths</surname>
                <given-names>WA</given-names>
              </name>
              <name>
                <surname>Venning</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Grabczynska</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Peris</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Kansky</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kelsell</surname>
                <given-names>DP</given-names>
              </name>
            </person-group>
            <article-title>Clinical and genetic heterogeneity of erythrokeratoderma variabilis.</article-title>
            <source>J Invest Dermatol</source>
            <year>2005</year>
            <month>Nov</month>
            <volume>125</volume>
            <issue>5</issue>
            <fpage>920</fpage>
            <page-range>920-7</page-range>
            <pub-id pub-id-type="pmid">16297190</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21309.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hendrix</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Greer</surname>
                <given-names>KE</given-names>
              </name>
            </person-group>
            <article-title>Erythrokeratodermia variabilis present at birth: case report and review of the literature.</article-title>
            <source>Pediatr Dermatol</source>
            <year>1995</year>
            <month>Dec</month>
            <volume>12</volume>
            <issue>4</issue>
            <fpage>351</fpage>
            <page-range>351-4</page-range>
            <pub-id pub-id-type="pmid">8747585</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21309.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hohl</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Towards a better classification of erythrokeratodermias.</article-title>
            <source>Br J Dermatol</source>
            <year>2000</year>
            <month>Dec</month>
            <volume>143</volume>
            <issue>6</issue>
            <fpage>1133</fpage>
            <page-range>1133-7</page-range>
            <pub-id pub-id-type="pmid">11122011</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21309.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vandersteen</surname>
                <given-names>PR</given-names>
              </name>
              <name>
                <surname>Muller</surname>
                <given-names>SA</given-names>
              </name>
            </person-group>
            <article-title>Erythrokeratodermia variabilis. An enzyme histochemical and ultrastructural study.</article-title>
            <source>Arch Dermatol</source>
            <year>1971</year>
            <month>Apr</month>
            <volume>103</volume>
            <issue>4</issue>
            <fpage>362</fpage>
            <page-range>362-70</page-range>
            <pub-id pub-id-type="pmid">4326389</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21309.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Itin</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Levy</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Sommacal-Schopf</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Schnyder</surname>
                <given-names>UW</given-names>
              </name>
            </person-group>
            <article-title>[Family study of erythrokeratodermia figurata variabilis].</article-title>
            <source>Hautarzt</source>
            <year>1992</year>
            <month>Aug</month>
            <volume>43</volume>
            <issue>8</issue>
            <fpage>500</fpage>
            <page-range>500-4</page-range>
            <pub-id pub-id-type="pmid">1506216</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21309.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Landau</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cohen-Bar-Dayan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hohl</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Ophir</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wolf</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Gat</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mevorah</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Erythrokeratodermia variabilis with erythema gyratum repens-like lesions.</article-title>
            <source>Pediatr Dermatol</source>
            <year>2002</year>
            <season>Jul-Aug</season>
            <volume>19</volume>
            <issue>4</issue>
            <fpage>285</fpage>
            <page-range>285-92</page-range>
            <pub-id pub-id-type="pmid">12220269</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21309.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rajagopalan</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Pulimood</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>George</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Jacob</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Erythrokeratoderma en cocardes.</article-title>
            <source>Clin Exp Dermatol</source>
            <year>1999</year>
            <month>May</month>
            <volume>24</volume>
            <issue>3</issue>
            <fpage>173</fpage>
            <page-range>173-4</page-range>
            <pub-id pub-id-type="pmid">10354172</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21309.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Singh</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Thappa</surname>
                <given-names>DM</given-names>
              </name>
            </person-group>
            <article-title>Erythrokeratoderma variabilis responding to low-dose isotretinoin.</article-title>
            <source>Pediatr Dermatol</source>
            <year>2010</year>
            <season>Jan-Feb</season>
            <volume>27</volume>
            <issue>1</issue>
            <fpage>111</fpage>
            <page-range>111-3</page-range>
            <pub-id pub-id-type="pmid">20199434</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
